SCHEMBL7007243

SCHEMBL7007243

c1ccc(OCc2ncco2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.50
SMN1; SMN2 Q16637 7/20 0.50
NPC1 O15118 6/20 0.50
POLB P06746 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
LTA4H P09960 1/20 0.47
KCNH2 Q12809 1/20 0.47
CES1 P23141 1/20 0.47
TSHR P16473 3/20 0.44
THRB P10828 1/20 0.44
KDM4E B2RXH2 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
NISCH Q9Y2I1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29743958 0.81 CYP11B1 (0.48) RAB9ASMN1; SMN2NPC1POLBALDH1A1
SCHEMBL20641502 0.81 CYP11B1 (0.48) RAB9ASMN1; SMN2NPC1POLBALDH1A1
SCHEMBL5759296 0.81 SMN1; SMN2 (0.36) RAB9ASMN1; SMN2NPC1POLBALDH1A1
SCHEMBL6691870 0.79 TSHR (0.54) RAB9ASMN1; SMN2NPC1POLBALDH1A1
SCHEMBL23405978 0.79 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL29743786 0.79 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2NPC1ALDH1A1MAPK1
SCHEMBL23406039 0.78 SMN1; SMN2 (0.49) RAB9ASMN1; SMN2NPC1POLBALDH1A1
SCHEMBL5757035 0.77 ACACB (0.30)
SCHEMBL9899792 0.76
SCHEMBL15474285 0.76 MAOB (0.44) RAB9ASMN1; SMN2NPC1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5557002-A Process for the preparation of biphenyl containing intermediates useful in making angiotensin II receptor antagonists EISAI CO., LTD. (JP) 1996-09-17 US claimed
US-5554757-A Process for the preparation of imidazopyridine derivatives, and intermediates therefore EISAI CO., LTD. (JP) 1996-09-10 US claimed
EP-0627433-A1 PROCESS FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE AND INTERMEDIATE Eisai Co., Ltd. (JP) 1994-12-07 EP claimed
JP-7061977-A None JP disclosed
JP-7061952-A None JP disclosed
EP-0627433-B1 PROCESS FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE AND INTERMEDIATE EISAI CO LTD (JP) 2003-03-05 EP disclosed
US-5700938-A Intermediates for imidazopyridine derivatives EISAI CO., LTD. (JP) 1997-12-23 US disclosed
US-5618969-A Intermediates for imidazopyridines EISAI CO., LTD. (JP) 1997-04-08 US disclosed
US-5608068-A Process for the preparation of imidazopyridine derivatives and intermediates EISAI CO., LTD. (JP) 1997-03-04 US disclosed
US-5587504-A Sulfonyloxy-biphenylcarboxylic ester derivatives which are intermediates EISAI CO., LTD. (JP) 1996-12-24 US disclosed
US-5583229-A Process for the preparation of imidazopyridine derivatives EISAI CO., LTD. (JP) 1996-12-10 US disclosed
US-5554757-A Process for the preparation of imidazopyridine derivatives, and intermediates therefore EISAI CO., LTD. (JP) 1996-09-10 US disclosed
JP-H0761952-A PRODUCTION OF HALOMETHYLBIPHENYLCARBOXYLIC ACID ESTER DERIVATIVE EISAI KAGAKU KK 1995-03-07 JP disclosed
JP-H0761977-A BIPHENYLOXAZOLINE DERIVATIVE EISAI KAGAKU KK 1995-03-07 JP disclosed
EP-0627433-A1 PROCESS FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE AND INTERMEDIATE Eisai Co., Ltd. (JP) 1994-12-07 EP disclosed
US-4839369-A ANTIINFLAMMATORY AGENTS; ANTIALLERGENS RORER PHARMACEUTICAL CORPORATION (US) 1989-06-13 US disclosed
US-4728668-A Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments USV PHARMACEUTICAL CORPORATION (US) 1988-03-01 US disclosed
US-4725619-A Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments USV PHARMACEUTICAL CORPORATION (US) 1988-02-16 US disclosed
US-4631287-A Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments USV PHARMACEUTICAL CORP. (US) 1986-12-23 US disclosed
EP-0200101-A2 Aryl and heteroaryl ethers as agents for the treatment of hypersensitive aliments USV PHARMACEUTICAL CORPORATION (US) 1986-11-05 EP disclosed